ATE228359T1 - Hemmung der leukotrienbiosynthese mittels harnstoffderivaten - Google Patents

Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Info

Publication number
ATE228359T1
ATE228359T1 AT95926593T AT95926593T ATE228359T1 AT E228359 T1 ATE228359 T1 AT E228359T1 AT 95926593 T AT95926593 T AT 95926593T AT 95926593 T AT95926593 T AT 95926593T AT E228359 T1 ATE228359 T1 AT E228359T1
Authority
AT
Austria
Prior art keywords
biosynthesis
leukotrie
inhibition
urea derivatives
compound
Prior art date
Application number
AT95926593T
Other languages
English (en)
Inventor
Stephen L Crooks
Bryon A Merrill
Paul D Wightman
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Application granted granted Critical
Publication of ATE228359T1 publication Critical patent/ATE228359T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95926593T 1994-08-04 1995-07-14 Hemmung der leukotrienbiosynthese mittels harnstoffderivaten ATE228359T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (1)

Publication Number Publication Date
ATE228359T1 true ATE228359T1 (de) 2002-12-15

Family

ID=26963530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95926593T ATE228359T1 (de) 1994-08-04 1995-07-14 Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Country Status (19)

Country Link
EP (1) EP0777471B1 (de)
JP (1) JPH10503771A (de)
AT (1) ATE228359T1 (de)
AU (1) AU685980B2 (de)
BR (1) BR9508521A (de)
CA (1) CA2196701A1 (de)
CZ (1) CZ287034B6 (de)
DE (1) DE69528984T2 (de)
DK (1) DK0777471T3 (de)
ES (1) ES2185708T3 (de)
FI (1) FI970452L (de)
HU (1) HUT76830A (de)
IL (1) IL114646A (de)
NO (1) NO315786B1 (de)
NZ (1) NZ290236A (de)
PL (1) PL180668B1 (de)
PT (1) PT777471E (de)
SK (1) SK282777B6 (de)
WO (1) WO1996003983A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066658A (en) * 1988-11-10 1991-11-19 Ortho Pharmaceutical Corporation Substituted hydroxyureas
EP0456760A4 (en) * 1989-02-01 1992-01-08 Abbott Laboratories Lipoxygenase inhibiting compounds
JP2528741B2 (ja) * 1991-01-09 1996-08-28 ファイザー製薬株式会社 オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物

Also Published As

Publication number Publication date
WO1996003983A1 (en) 1996-02-15
MX9700860A (es) 1997-10-31
NO970477D0 (no) 1997-02-03
NZ290236A (en) 1998-12-23
NO315786B1 (no) 2003-10-27
HUT76830A (en) 1997-11-28
BR9508521A (pt) 1997-10-28
FI970452A7 (fi) 1997-02-03
DE69528984T2 (de) 2003-09-04
PL318539A1 (en) 1997-06-23
NO970477L (no) 1997-03-14
IL114646A (en) 2000-02-29
CA2196701A1 (en) 1996-02-15
PT777471E (pt) 2003-04-30
CZ31297A3 (en) 1997-09-17
CZ287034B6 (en) 2000-08-16
FI970452A0 (fi) 1997-02-03
SK11097A3 (en) 1997-09-10
ES2185708T3 (es) 2003-05-01
AU3091795A (en) 1996-03-04
AU685980B2 (en) 1998-01-29
PL180668B1 (pl) 2001-03-30
DK0777471T3 (da) 2003-03-17
EP0777471A1 (de) 1997-06-11
EP0777471B1 (de) 2002-11-27
JPH10503771A (ja) 1998-04-07
DE69528984D1 (de) 2003-01-09
IL114646A0 (en) 1995-11-27
FI970452L (fi) 1997-02-03
SK282777B6 (sk) 2002-12-03

Similar Documents

Publication Publication Date Title
DE69831868D1 (en) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
DK0889875T3 (da) Cycloproylalkansyrederivater
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
MX9701538A (es) Sales de un derivado del indol contra la migraña.
AP9701041A0 (en) Pyridylpyrrole compounds.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
BR9506552A (pt) Método de inibição de integrase retroviral
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
ATE229800T1 (de) Guanidino proteiase inhibitoren
DE69330601D1 (de) Serotoninergische ergolin derivate
AU5390900A (en) Potassium channel blocking agents
NZ331256A (en) Benzo[c]quinolizine derivatives, their preparation and use as 5 alpha-reductases inhibitors
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
AR015458A1 (es) Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene.
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0777471

Country of ref document: EP

REN Ceased due to non-payment of the annual fee